Planet Labs PBC (PL)
Planet Labs PBC (PL)
| Cash Flow | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 |
|---|---|---|---|---|
| Revenue | NaN | NaN | NaN | 73,386 |
| Cost of revenue | NaN | NaN | NaN | 20,590 |
| Research and development expense | NaN | NaN | NaN | 18,375 |
| Sales and marketing | NaN | NaN | NaN | 15,432 |
| General and administrative | NaN | NaN | NaN | 12,582 |
| Depreciation and amortization | NaN | NaN | NaN | 10,622 |
| Stock-based compensation | NaN | NaN | NaN | 13,456 |
| Restructuring costs | NaN | NaN | NaN | 0 |
| Certain litigation expenses | NaN | NaN | NaN | 289 |
| Other segment items | NaN | NaN | NaN | 4,632 |
| Net loss | -138,872 | -152,455 | -59,185 | -22,592 |
| Depreciation and amortization | 11,189 | 10,213 | 9,908 | 10,622 |
| Stock-based compensation, net of capitalized cost of 455 and 673, respectively | 16,461 | 15,524 | 13,473 | 13,456 |
| Change in fair value of warrant liabilities | 106,474 | 122,635 | 43,473 | 5,679 |
| Change in fair value of contingent consideration | 0 | -1,606 | 1,395 | 717 |
| Other | -331 | -547 | 234 | 309 |
| Accounts receivable | -22,466 | 37,569 | -4,981 | -23,548 |
| Inventories | 731 | 609 | NaN | NaN |
| Prepaid expenses and other assets | 3,357 | 12,190 | -780 | 982 |
| Accounts payable, accrued and other liabilities | 4,081 | 24,120 | -5,978 | 4,573 |
| Deferred revenue | -1,143 | 54,431 | 20,810 | 33,741 |
| Deferred hosting costs | -797 | -1,298 | -1,298 | -1,297 |
| Net cash provided by operating activities | 15,440 | 20,649 | 28,593 | 67,774 |
| Purchases of property and equipment | 17,310 | 21,600 | 26,704 | 20,291 |
| Capitalized internal-use software | 647 | 1,385 | 978 | 1,195 |
| Maturities of available-for-sale securities | 37,487 | 44,992 | 17,886 | 16,008 |
| Sales of available-for-sale securities | 44,525 | 150 | 23,825 | 8,672 |
| Purchases of available-for-sale securities | 33,367 | 220,870 | 184,777 | 22,361 |
| Business acquisition, net of cash acquired | NaN | 5,400 | 0 | 0 |
| Purchases of licensed imagery intangible assets | 274 | 298 | 261 | 271 |
| Other | NaN | 0 | 0 | 0 |
| Net cash provided by investing activities | 30,414 | -204,411 | -171,009 | -19,438 |
| Proceeds from the exercise of common stock options | 3,552 | 7,776 | 11,481 | 5,489 |
| Payments for withholding taxes related to the net share settlement of equity awards | 17,340 | 44,410 | 15,883 | 7,172 |
| Proceeds from employee stock purchase program | 1,328 | 951 | 688 | 817 |
| Payments of contingent consideration for business acquisitions | 0 | 0 | -773 | 0 |
| Payment of indemnification holdback for business acquisition | NaN | 0 | 5,000 | NaN |
| Proceeds from issuance of convertible notes, net of discount | NaN | 0 | 448,759 | NaN |
| Payment of debt issuance costs | NaN | 0 | 2,929 | NaN |
| Proceeds from the exercise of warrants | 107,801 | 4,781 | 64 | NaN |
| Purchase of capped call transactions | NaN | 0 | 39,560 | NaN |
| Other | -138 | -138 | -138 | -138 |
| Net cash provided by (used in) financing activities | 95,203 | -31,040 | 398,255 | -1,004 |
| Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents | -1,015 | 734 | 853 | -6 |
| Net increase in cash and cash equivalents, and restricted cash and cash equivalents | 140,042 | -214,068 | 256,692 | 47,326 |
| Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period | 235,554 | 449,622 | 192,930 | 145,604 |
| Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period | 375,596 | 235,554 | 449,622 | 192,930 |